Abstract
Compelling new evidence supports the idea that regulatory T cells play a major role in our immune system. Several subsets of these regulators have been identified recently. Differences in the phenotypical and functional characteristics of these subsets have immunological implications. From our growing knowledge of the field of immunology, we could potentially generate a new class of therapeutic agents that target immune-related diseases.
MeSH terms
-
Adjuvants, Immunologic / therapeutic use
-
Animals
-
CD4-Positive T-Lymphocytes / immunology
-
CD4-Positive T-Lymphocytes / physiology
-
Drug Delivery Systems
-
Humans
-
Immune Tolerance
-
Receptors, Interleukin-2 / immunology
-
Receptors, Interleukin-2 / physiology
-
T-Lymphocyte Subsets / drug effects
-
T-Lymphocyte Subsets / immunology
-
T-Lymphocytes / drug effects*
-
T-Lymphocytes / immunology
Substances
-
Adjuvants, Immunologic
-
Receptors, Interleukin-2